p53-Induced growth arrest is regulated by the Mitochondrial SirT3 deacetylase

PLoS ONE

Volumn 5, Issue 5, 2010, Pages

  Li, SiDe ^a   Banck, Michaela ^b   Mujtaba, Shiraz ^a   Zhou, Ming Ming ^a   Sugrue, Mary M ^a,c   Walsh, Martin J ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

^c CELGENE CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; MITOCHONDRIAL PROTEIN; PROTEIN BCL 2; PROTEIN P53; SIRTUIN 3; BAG2 PROTEIN, HUMAN; HEAT SHOCK PROTEIN 70; NICOTINAMIDE ADENINE DINUCLEOTIDE; SIRT3 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; BLADDER CARCINOMA; CARCINOMA CELL; CELL AGING; CELL CYCLE ARREST; CELL GROWTH; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MITOCHONDRION; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TARGETING; TRANSCRIPTION INITIATION; ACETYLATION; BLADDER TUMOR; CELL FRACTIONATION; CELL PROLIFERATION; CHEMISTRY; ENZYMOLOGY; GENE DELETION; METABOLISM; PATHOLOGY; PROTEIN BINDING; PROTEIN STABILITY; PROTEIN TERTIARY STRUCTURE; PROTEIN TRANSPORT; TUMOR CELL LINE;

ACETYLATION; CELL AGING; CELL LINE, TUMOR; CELL PROLIFERATION; GENE DELETION; HSP70 HEAT-SHOCK PROTEINS; HUMANS; MITOCHONDRIA; NAD; PHENOTYPE; PROTEIN BINDING; PROTEIN STABILITY; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-BCL-2; SIRTUIN 3; SUBCELLULAR FRACTIONS; TUMOR SUPPRESSOR PROTEIN P53; URINARY BLADDER NEOPLASMS;

EID: 77956295588     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010486     Document Type: Article

References (60)

1. Talos F, Petrenko O, Mena P, Moll UM (2005) Mitochondrially targeted p53 has tumor suppressor activities in vivo. Cancer Res 65: 9971-9981.
2. Sugrue MM, Shin DY, Lee SW, Aaronson SA (1997) Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53. Proc Natl Acad Sci U S A 94: 9648-9653.
3. Moll UM, Wolff S, Speidel D, Deppert W (2005) Transcription-independent pro-apoptotic functions of p53. Curr Opin Cell Biol 17: 631-636.
4. Langley E, Pearson M, Faretta M, Bauer UM, Frye RA, et al. (2002) Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. Embo J 21: 2383-2396.
5. Solomon JM, Pasupuleti R, Xu L, McDonagh T, Curtis R, et al. (2006) Inhibition of SIRT1 catalytic activity increases p53 acetylation but does not alter cell survival following DNA damage. Mol Cell Biol 26: 28-38.
6. Buck SW, Gallo CM, Smith JS (2004) Diversity in the Sir2 family of protein deacetylases. J Leukoc Biol 75: 939-950.
7. Anderson RM, Bitterman KJ, Wood JG, Medvedik O, Sinclair DA (2003) Nicotinamide and PNC1 govern lifespan extension by calorie restriction in Saccharomyces cerevisiae. Nature 423: 181-185.
8. Michishita E, Park JY, Burneskis JM, Barrett JC, Horikawa I (2005) Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Mol Biol Cell 16: 4623-4635.
9. Moazed D (2001) Enzymatic activities of Sir2 and chromatin silencing. Curr Opin Cell Biol 13: 232-238.
10. Shore D (2001) Telomeric chromatin: replicating and wrapping up chromosome ends. Curr Opin Genet Dev 11: 189-198.
11. Cheng HL, Mostoslavsky R, Saito S, Manis JP, Gu Y, et al. (2003) Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)- deficient mice. Proc Natl Acad Sci U S A 100: 10794-10799.
12. Schwer B, North BJ, Frye RA, Ott M, Verdin E (2002) The human silent information regulator (Sir)2 homologue hSIRT3 is a mitochondrial nicotinamide adenine dinucleotide-dependent deacetylase. J Cell Biol 158: 647-657.
13. Onyango P, Celic I, McCaffery JM, Boeke JD, Feinberg AP (2002) SIRT3, a human SIR2 homologue, is an NAD-dependent deacetylase localized to mitochondria. Proc Natl Acad Sci U S A 99: 13653-13658.
14. Shi T, Wang F, Stieren E, Tong Q (2005) SIRT3, a mitochondrial sirtuin deacetylase, regulates mitochondrial function and thermogenesis in brown adipocytes. J Biol Chem 280: 13560-13567.
15. Vaquero A, Sternglanz R, Reinberg D (2007) NAD+-dependent deacetylation of H4 lysine 16 by class III HDACs. Oncogene 26: 5505-5520.
16. Scher MB, Vaquero A, Reinberg D (2007) SirT3 is a nuclear NAD+-dependent histone deacetylase that translocates to the mitochondria upon cellular stress. Genes Dev 21: 920-928.
17. Sundaresan NR, Samant SA, Pillai VB, Rajamohan SB, Gupta MP (2008) SIRT3 is a stress-responsive deacetylase in cardiomyocytes that protects cells from stress-mediated cell death by deacetylation of Ku70. Mol Cell Biol 28: 6384-6401.
18. Sundaresan NR, Gupta M, Kim G, Rajamohan SB, Isbatan A, et al. (2009) Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice. J Clin Invest 119: 2758-2771.
19. Lombard DB, Alt FW, Cheng HL, Bunkenborg J, Streeper RS, et al. (2007) Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation. Mol Cell Biol 27: 8807-8814.
20. Hallows WC, Lee S, Denu JM (2006) Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases. Proc Natl Acad Sci U S A 103: 10230-10235.
21. Schwer B, Bunkenborg J, Verdin RO, Andersen JS, Verdin E (2006) Reversible lysine acetylation controls the activity of the mitochondrial enzyme acetyl-CoA synthetase 2. Proc Natl Acad Sci U S A 103: 10224-10229.
22. Lavin MF, Gueven N (2006) The complexity of p53 stabilization and activation. Cell Death Differ 13: 941-950.
23. Walerych D, Kudla G, Gutkowska M, Wawrzynow B, Muller L, et al. (2004) Hsp90 chaperones wild-type p53 tumor suppressor protein. J Biol Chem 279: 48836-48845.
24. Esser C, Scheffner M, Hohfeld J (2005) The chaperone-associated ubiquitin ligase CHIP is able to target p53 for proteasomal degradation. J Biol Chem 280: 27443-27448.
25. Tripathi V, Ali A, Bhat R, Pati U (2007) CHIP Chaperones Wild Type p53 Tumor Suppressor Protein. J Biol Chem 282: 28441-28454.
26. Arndt V, Daniel C, Nastainczyk W, Alberti S, Hohfeld J (2005) BAG-2 acts as an inhibitor of the chaperone-associated ubiquitin ligase CHIP. Mol Biol Cell 16: 5891-5900.
27. Ahn BY, Trinh DL, Zajchowski LD, Lee B, Elwi AN, et al. (2009) Tid1 is a new regulator of p53 mitochondrial translocation and apoptosis in cancer. Oncogene.
28. Sugrue MM, Wang Y, Rideout HJ, Chalmers-Redman RM, Tatton WG (1999) Reduced mitochondrial membrane potential and altered responsiveness of a mitochondrial membrane megachannel in p53-induced senescence. Biochem Biophys Res Commun 261: 123-130.
29. Mihara M, Erster S, Zaika A, Petrenko O, Chittenden T, et al. (2003) p53 has a direct apoptogenic role at the mitochondria. Mol Cell 11: 577-590.
30. Tomita Y, Marchenko N, Erster S, Nemajerova A, Dehner A, et al. (2006) WT p53, but not tumor-derived mutants, bind to Bcl2 via the DNA binding domain and induce mitochondrial permeabilization. J Biol Chem 281: 8600-8606.
31. Nemajerova A, Erster S, Moll UM (2005) The post-translational phosphorylation and acetylation modification profile is not the determining factor in targeting endogenous stress-induced p53 to mitochondria. Cell Death Differ 12: 197-200.
32. Bargonetti J, Manfredi JJ (2002) Multiple roles of the tumor suppressor p53. Curr Opin Oncol 14: 86-91.
33. Fang L, Igarashi M, Leung J, Sugrue MM, Lee SW, et al. (1999) p21Waf1/ Cip1/Sdi1 induces permanent growth arrest with markers of replicative senescence in human tumor cells lacking functional p53. Oncogene 18: 2789-2797.
34. Jardine LJ (2004) Identification of senescence in cancer cells. Methods Mol Med 88: 231-238.
35. Coates PJ, Nenutil R, McGregor A, Picksley SM, Crouch DH, et al. (2001) Mammalian prohibitin proteins respond to mitochondrial stress and decrease during cellular senescence. Exp Cell Res 265: 262-273.
36. Zhu J, Jiang J, Zhou W, Zhu K, Chen X (1999) Differential regulation of cellular target genes by p53 devoid of the PXXP motifs with impaired apoptotic activity. Oncogene 18: 2149-2155.
37. Ben-Porath I, Weinberg RA (2005) The signals and pathways activating cellular senescence. Int J Biochem Cell Biol 37: 961-976.
38. Hannon GJ, Sun P, Carnero A, Xie LY, Maestro R, et al. (1999) MaRX: an approach to genetics in mammalian cells. Science 283: 1129-1130.
39. Blander G, Guarente L (2004) The Sir2 family of protein deacetylases. Annu Rev Biochem 73: 417-435.
40. Andersen CL, Hostetter G, Grigoryan A, Sauter G, Kallioniemi A (2001) Improved procedure for fluorescence in situ hybridization on tissue microarrays. Cytometry 45: 83-86.
41. Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, et al. (2004) Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. Embo J 23: 2369-2380.
42. Vaquero A, Scher M, Lee D, Erdjument-Bromage H, Tempst P, et al. (2004) Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin. Mol Cell 16: 93-105.
43. Marchenko ND, Wolff S, Erster S, Becker K, Moll UM (2007) Monoubiquitylation promotes mitochondrial p53 translocation. Embo J 26: 923-934.
44. Marchenko ND, Moll UM (2007) The role of ubiquitination in the direct mitochondrial death program of p53. Cell Cycle 6: 1718-1723.
45. Gu W, Luo J, Brooks CL, Nikolaev AY, Li M (2004) Dynamics of the p53 acetylation pathway. Novartis Found Symp 259: 197-205; discussion 205-197, 223-195.
46. Luo J, Nikolaev AY, Imai S, Chen D, Su F, et al. (2001) Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 107: 137-148.
47. Tang X, Gao JS, Guan YJ, McLane KE, Yuan ZL, et al. (2007) Acetylationdependent signal transduction for type I interferon receptor. Cell 131: 93-105.
48. Allison SJ, Milner J (2007) SIRT3 is pro-apoptotic and participates in distinct basal apoptotic pathways. Cell Cycle 6: 2669-2677.
49. Yang H, Yang T, Baur JA, Perez E, Matsui T, et al. (2007) Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival. Cell 130: 1095-1107.
50. Hohfeld J, Cyr DM, Patterson C (2001) From the cradle to the grave: molecular chaperones that may choose between folding and degradation. EMBO Rep 2: 885-890.
51. Esser C, Alberti S, Hohfeld J (2004) Cooperation of molecular chaperones with the ubiquitin/proteasome system. Biochim Biophys Acta 1695: 171-188.
52. Dai Q, Zhang C, Wu Y, McDonough H, Whaley RA, et al. (2003) CHIP activates HSF1 and confers protection against apoptosis and cellular stress. Embo J 22: 5446-5458.
53. Mosser DD, Morimoto RI (2004) Molecular chaperones and the stress of oncogenesis. Oncogene 23: 2907-2918.
54. Zhu J, Gao B, Zhao J, Balmain A (2000) Targeting gene expression to tumor cells with loss of wild-type p53 function. Cancer Gene Ther 7: 4-12.
55. Marchenko ND, Zaika A, Moll UM (2000) Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling. J Biol Chem 275: 16202-16212.
56. Kume A, Hashiyama M, Suda T, Ozawa K (1999) Green fluorescent protein as a selectable marker of retrovirally transduced hematopoietic progenitors. Stem Cells 17: 226-232.
57. Walsh MJ, Shue G, Spidoni K, Kapoor A (1995) E2F-1 and a cyclin-like DNA repair enzyme, uracil-DNA glycosylase, provide evidence for an autoregulatory mechanism for transcription. J Biol Chem 270: 5289-5298.
58. Imai S, Armstrong CM, Kaeberlein M, Guarente L (2000) Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403: 795-800.
59. Li S, Moy L, Pittman N, Shue G, Aufiero B, et al. (1999) Transcriptional repression of the cystic fibrosis transmembrane conductance regulator gene, mediated by CCAAT displacement protein/cut homolog, is associated with histone deacetylation. J Biol Chem 274: 7803-7815.
60. Li S, Aufiero B, Schiltz RL, Walsh MJ (2000) Regulation of the homeodomain CCAAT displacement/cut protein function by histone acetyltransferases p300/ CREB-binding protein (CBP)-associated factor and CBP. Proc Natl Acad Sci U S A 97: 7166-7171.